- CA$2.54bn
- CA$6.37bn
- CA$2.63bn
- 77
- 68
- 74
- 85
C2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,122 | 2,049 | 2,170 | 2,426 | 2,627 |
Cost of Revenue | |||||
Gross Profit | 1,916 | 1,795 | 1,773 | 2,020 | 2,187 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,339 | 1,338 | 1,474 | 1,706 | 2,262 |
Operating Profit | 784 | 710 | 696 | 720 | 365 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 727 | 643 | 586 | 476 | 150 |
Provision for Income Taxes | |||||
Net Income After Taxes | 538 | 476 | 412 | 302 | 6.09 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 538 | 476 | 409 | 300 | 5.02 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 538 | 476 | 409 | 300 | 5.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.29 | 2.42 | 2.23 | 1.81 | 0.673 |
Dividends per Share |